✦ LIBER ✦

Process Development and Scale-Up for the Preparation of the 1-Methyl-quinazoline-2,4-dione Wnt Inhibitor SEN461

✍ Scribed by Betti, Matteo; Genesio, Eva; Panico, Alessandro; Sanna Coccone, Salvatore; Wiedenau, Paul

Book ID: 120928248
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 415 KB
Volume: 17
Category: Article
ISSN: 1083-6160
DOI: 10.1021/op400145w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Process Development for Scale-Up of a No

Process Development for Scale-Up of a Novel 3,5-Substituted Thiazolidine-2,4-dione Compound as a Potent Inhibitor for Estrogen-Related Receptor 1

✍ Li, Xun; Russell, Ronald K.; Spink, Jan; Ballentine, Scott; Teleha, Christopher; 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 876 KB

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-yn

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes†

✍ Eckhardt, Matthias; Langkopf, Elke; Mark, Michael; Tadayyon, Moh; Thomas, Leo; N 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 235 KB

Fundamentals of Early Clinical Drug Deve

Fundamentals of Early Clinical Drug Development (From Synthesis Design to Formulation) || Development and Scale-Up of a Heterocyclic Cross-Coupling for the Synthesis of 5-[2-(3-Methyl-3 H -imidazol-4-yl)-thieno[3,2- b ]pyridine-7-yl] amino-2-methyl-1 H -indole

✍ Abdel-Magid, Ahmed F.; Caron, Stéphane 📂 Article 📅 2006 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 376 KB

Using Recent Examples And Important Case Studies, The Fundamentals Of Early Clinical Drug Development: From Synthesis Design To Formulation Demonstrates The Central Role℗¡that Organic Synthesis Plays In The Early Clinical Evaluation Of Potential Drug Candidates. Reflections On Process Research Ii /

The Ceiling Effect of Pharmacological Po

The Ceiling Effect of Pharmacological Postconditioning with the Phytoestrogen Genistein Is Reversed by the GSK3 Inhibitor SB 216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through Mitochondrial ATP-Dependent Potassium Channel Opening

✍ Couvreur, N.; Tissier, R.; Pons, S.; Chenoune, M.; Waintraub, X.; Berdeaux, A.; 📂 Article 📅 2009 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 358 KB